. . "12" . "CZ - \u010Cesk\u00E1 republika" . "Secondary endocrine hypertension"@en . . "Medic\u00EDna pro praxi" . . "228613" . . "Sekund\u00E1rn\u00ED endokrinn\u00ED hypertenze" . . . "Secondary endocrine hypertension is 1-5% of all hypertension. Etiology may be a primary aldosteronism and other mineralocorticoid hypertension, Cushing syndrome, pheochromocytoma, hyperparathyroidism, acromegaly, hyperthyroidism, hypothyroidism, and some other less common endocrine disorders. The first three are often among the causes of resistant hypertension. Detection and elimination of secondary causes for the patient can mean a complete cure."@en . "1"^^ . "Sekund\u00E1rn\u00ED endokrinn\u00ED hypertenze"@cs . "1214-8687" . . "1"^^ . . "P(OVUVN20090001)" . . . "Sekund\u00E1rn\u00ED endokrinn\u00ED hypertenze tvo\u0159\u00ED 1-5% v\u0161ech hypertenz\u00ED. Etiologicky se mezi n\u011B \u0159ad\u00ED prim\u00E1rn\u00ED hyperaldosteronismus a ostatn\u00ED mineralokortikoidn\u00ED hypertenze, Cushing\u016Fv syndrom, feochromocytom, hyperparatyre\u00F3za, akromegalie, hypertyre\u00F3za, hypotyre\u00F3za a n\u011Bkter\u00E9 jin\u00E9 m\u00E9n\u011B \u010Dast\u00E9 endokrinopatie. Prvn\u00ED t\u0159i jmenovan\u00E9 p\u0159\u00ED\u010Diny \u010Dasto pat\u0159\u00ED mezi rezistentn\u00ED hypertenze. Odhalen\u00ED a odstran\u011Bn\u00ED sekund\u00E1rn\u00ED p\u0159\u00ED\u010Diny m\u016F\u017Ee pro pacienta znamenat i \u00FApln\u00E9 vyl\u00E9\u010Den\u00ED."@cs . "Sekund\u00E1rn\u00ED endokrinn\u00ED hypertenze" . "[FBD8A63114C7]" . . "8" . . . . . . "Secondary endocrine hypertension"@en . "Sekund\u00E1rn\u00ED endokrinn\u00ED hypertenze"@cs . "Drbalov\u00E1, Karol\u00EDna" . . "RIV/61383082:_____/11:0033" . "RIV/61383082:_____/11:0033!RIV12-MO0-61383082" . . "4"^^ . . "secondary hypertension; hyperaldosteronism; Cushing syndrome; pheochromocytoma; hyperparathyroidism; acromegaly; cortisol; aldosterone; metanephrine; parathyroid hormone; growth hormon"@en . . "Sekund\u00E1rn\u00ED endokrinn\u00ED hypertenze tvo\u0159\u00ED 1-5% v\u0161ech hypertenz\u00ED. Etiologicky se mezi n\u011B \u0159ad\u00ED prim\u00E1rn\u00ED hyperaldosteronismus a ostatn\u00ED mineralokortikoidn\u00ED hypertenze, Cushing\u016Fv syndrom, feochromocytom, hyperparatyre\u00F3za, akromegalie, hypertyre\u00F3za, hypotyre\u00F3za a n\u011Bkter\u00E9 jin\u00E9 m\u00E9n\u011B \u010Dast\u00E9 endokrinopatie. Prvn\u00ED t\u0159i jmenovan\u00E9 p\u0159\u00ED\u010Diny \u010Dasto pat\u0159\u00ED mezi rezistentn\u00ED hypertenze. Odhalen\u00ED a odstran\u011Bn\u00ED sekund\u00E1rn\u00ED p\u0159\u00ED\u010Diny m\u016F\u017Ee pro pacienta znamenat i \u00FApln\u00E9 vyl\u00E9\u010Den\u00ED." . . . .